Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
IST:SURGY's 5-Year Yield-on-Cost % is not ranked *
in the Real Estate industry.
Industry Median: 3.79 * Ranked among companies with meaningful 5-Year Yield-on-Cost % only.
Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.
Sur Tatil Evleri Gayrimenkul Yatirim Ortakligi 5-Year Yield-on-Cost % Related Terms
For the Real Estate - Development subindustry, Sur Tatil Evleri Gayrimenkul Yatirim Ortakligi's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sur Tatil Evleri Gayrimenkul Yatirim Ortakligi 5-Year Yield-on-Cost % vs Real Estate Industry
Sur Tatil Evleri Gayrimenkul Yatirim Ortakligi 5-Year Yield-on-Cost % Calculation
Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.
Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.
Sur Tatil Evleri Gayrimenkul Yatirim Ortakligi (IST:SURGY) has a 5-Year Yield-on-Cost % of 0.00 as of Aug. 23, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Sur Tatil Evleri Gayrimenkul Yatirim Ortakligi and its competitors. According to the industry distribution chart, Sur Tatil Evleri Gayrimenkul Yatirim Ortakligi ranks #999999 out of 858 companies in the Real Estate industry.
Is Sur Tatil Evleri Gayrimenkul Yatirim Ortakligi's 5-Year Yield-on-Cost % too high?
Sur Tatil Evleri Gayrimenkul Yatirim Ortakligi's current 5-Year Yield-on-Cost % is 0.00. Based on the distribution chart, Sur Tatil Evleri Gayrimenkul Yatirim Ortakligi ranks #999999 out of 858 companies in the Real Estate industry, which is in the bottom quartile relative to peers. Overall, Sur Tatil Evleri Gayrimenkul Yatirim Ortakligi has a GF Score™ of 13/100, reflecting its overall financial health beyond just this single metric.
How does Sur Tatil Evleri Gayrimenkul Yatirim Ortakligi's 5-Year Yield-on-Cost % compare to competitors?
According to the Real Estate industry distribution chart, Sur Tatil Evleri Gayrimenkul Yatirim Ortakligi ranks #999999 out of 858 companies for 5-Year Yield-on-Cost %. This places Sur Tatil Evleri Gayrimenkul Yatirim Ortakligi in the lower half of its industry. The industry median 5-Year Yield-on-Cost % is 3.79. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Real Estate company?
The median 5-Year Yield-on-Cost % among Real Estate companies is 3.79, based on 858 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Sur Tatil Evleri Gayrimenkul Yatirim Ortakligi and its competitors. For the Real Estate industry, the median 5-Year Yield-on-Cost % is 3.79 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sur Tatil Evleri Gayrimenkul Yatirim Ortakligi's current 5-Year Yield-on-Cost % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sur Tatil Evleri Gayrimenkul Yatirim Ortakligi stock overvalued right now?
Sur Tatil Evleri Gayrimenkul Yatirim Ortakligi (IST:SURGY) has a current 5-Year Yield-on-Cost % of 0.00. The current 5-Year Yield-on-Cost % is 0.00. Sur Tatil Evleri Gayrimenkul Yatirim Ortakligi's overall GF Score™ is 13/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For Sur Tatil Evleri Gayrimenkul Yatirim Ortakligi (IST:SURGY), the current 5-Year Yield-on-Cost % is 0.00 as of Aug. 23, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Sur Tatil Evleri Gayrimenkul Yatirim Ortakligi is a company that carries out all kinds of construction contracting works which is to construct and sell residences, workplaces and commercial buildings, also to purchase land and plots for one's own account, and to build buildings in return for flats on these or on lands belonging to others.
13GF Score
Get the complete analysis for IST:SURGY
5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
IST:SURGY has been successfully added to your 
